Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

NICE rejects Novartis migraine treatment Aimovig

NICE rejects Novartis migraine treatment Aimovig

Botox is normally offered to patients when at least three oral preventative treatments have been tried for those with chronic migraine. ... Despite this, a report by ICER, US pricing watchdog, says Aimovig would only be cost-effective if used after Botox

Teva wins FDA OK for crucial migraine drug

Teva wins FDA OK for crucial migraine drug 900 before rebates and discounts – exactly the same level as Novartis and Amgen positioned Aimovig, and in line with stablished therapies like Allergan’s Botox. ... other preventive options such as Botox and anti-epilepsy drugs like topiramate

CGRP migraine drugs need prior approval for use, recommends ICER

CGRP migraine drugs need prior approval for use, recommends ICER that it offered value for money, but only if other migraine prevention options such as Allergan’s Botox and anti-epilepsy drugs such as topiramate had been exhausted.

ICER says price of Amgen/Novartis’ Aimovig is OK - if used last-line

ICER says price of Amgen/Novartis’ Aimovig is OK - if used last-line That includes drugs such as Allergan’s Botox, which costs around $3, 500 per year, as well as certain anti-epilepsy drugs such as topiramate.

Novartis, Amgen set low price for first CGRP migraine drug

Novartis, Amgen set low price for first CGRP migraine drug medicines such as the anticonvulsant topiramate or Allergan's Botox. ... As a migraine treatment Botox costs around $3, 500 per year, and analysts predict that the annual price for Aimovig will drop to around $5, 000 with rebates and discounts.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics